| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76597538af7ebb69bb063d3fe5007292 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-515 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 |
| filingDate |
2001-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b188abd28cc977d78677c7dc0684b79 |
| publicationDate |
2003-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003134341-A1 |
| titleOfInvention |
Th1 cell adoptive immunotherapy |
| abstract |
A method for consistently producing a pure population of activated, polyclonal, Th1 memory cells for use in adoptive immunotherapy without the use of any exogenous cytokines and without significant subject-to-subject variation is provided. These cells obtain a surface phenotype that enables their trafficking to tumors and other sites of inflammation upon infusion and can be reinfused into the a subject to enhance the cellular immune response and/or switch the predominant immune response from Th2-dominated to a Th1-dominated immune response. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005084967-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8617884-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7977095-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6797514-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002119568-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9528088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002019048-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003235908-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004175373-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009137017-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003119185-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009148404-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011084479-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023137472-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006121005-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023137471-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005118173-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6867041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11046782-B2 |
| priorityDate |
2001-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |